The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of SY-5007, a highly potent and selective RET inhibitor, in Chinese patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC): Results from a multicenter, single-arm, phase II study.
 
Anwen Xiong
No Relationships to Disclose
 
XingYa Li
No Relationships to Disclose
 
Nong Yang
No Relationships to Disclose
 
Xiangjiao Meng
No Relationships to Disclose
 
Qitao Yu
No Relationships to Disclose
 
Liping Tan
No Relationships to Disclose
 
Qiming Wang
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Baogang Liu
No Relationships to Disclose
 
Hui Luo
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Dingzhi Huang
No Relationships to Disclose
 
Yiping Zhang
No Relationships to Disclose
 
Zhengbo Song
No Relationships to Disclose
 
Feng Ye
No Relationships to Disclose
 
Jian Fang
No Relationships to Disclose
 
Mingfang Zhao
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Yinghui Sun
Employment - Shouyao Holdings (Beijing) Co., Ltd, Beijing, China
Leadership - Shouyao Holdings (Beijing) Co., Ltd, Beijing, China
Stock and Other Ownership Interests - Shouyao Holdings (Beijing) Co., Ltd, Beijing, China
Honoraria - Shouyao Holdings (Beijing) Co., Ltd, Beijing, China
 
Caicun Zhou
No Relationships to Disclose